Literature DB >> 26775793

Enhanced expression of melanoma progression markers in mouse model of sleep apnea.

S Perini1, D Martinez2, C C Montanari3, C Z Fiori4.   

Abstract

INTRODUCTION: Obstructive sleep apnea has been associated with higher cancer incidence and mortality. Increased melanoma aggressivity was reported in obstructive sleep apnea patients. Mice exposed to intermittent hypoxia (IH) mimicking sleep apnea show enhanced melanoma growth. Markers of melanoma progression have not been investigated in this model.
OBJECTIVE: The present study examined whether IH affects markers of melanoma tumor progression.
METHODS: Mice were exposed to isocapnic IH to a nadir of 8% oxygen fraction for 14 days. One million B16F10 melanoma cells were injected subcutaneously. Immunohistochemistry staining for Ki-67, PCNA, S100-beta, HMB-45, Melan-A, TGF-beta, Caspase-1, and HIF-1alpha were quantified using Photoshop.
RESULTS: Percentage of positive area stained was higher in IH than sham IH group for Caspase-1, Ki-67, PCNA, and Melan-A. The greater expression of several markers of tumor aggressiveness, including markers of ribosomal RNA transcription (Ki-67) and of DNA synthesis (PCNA), in mice exposed to isocapnic IH than in controls provide molecular evidence for a apnea-cancer relationship.
CONCLUSIONS: These findings have potential repercussions in the understanding of differences in clinical course of tumors in obstructive sleep apnea patients. Further investigation is necessary to confirm mechanisms of these descriptive results.
Copyright © 2015 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Apnea; Biological markers; Melanoma

Mesh:

Substances:

Year:  2016        PMID: 26775793     DOI: 10.1016/j.rppnen.2015.11.004

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN: 0873-2159


  6 in total

1.  Five-year relative survival in sleep apnea patients with a subsequent cancer diagnosis.

Authors:  Arthur Sillah; Faiza Faria; Nathaniel F Watson; David Gozal; Amanda I Phipps
Journal:  J Clin Sleep Med       Date:  2020-02-06       Impact factor: 4.062

Review 2.  Cancer and Sleep Apnea: Cutaneous Melanoma as a Case Study.

Authors:  Miguel Angel Martinez-Garcia; Francisco Campos-Rodriguez; Isaac Almendros; Francisco Garcia-Rio; Manuel Sanchez-de-la-Torre; Ramon Farre; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

3.  Sleep problems and risk of cancer incidence and mortality in an older cohort: The Cardiovascular Health Study (CHS).

Authors:  Arthur Sillah; Nathaniel F Watson; Ulrike Peters; Mary L Biggs; F Javier Nieto; Christopher I Li; David Gozal; Timothy Thornton; Sonnah Barrie; Amanda I Phipps
Journal:  Cancer Epidemiol       Date:  2021-11-17       Impact factor: 2.984

Review 4.  Sleep Apnoea Adverse Effects on Cancer: True, False, or Too Many Confounders?

Authors:  David Gozal; Isaac Almendros; Amanda I Phipps; Francisco Campos-Rodriguez; Miguel A Martínez-García; Ramon Farré
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

5.  Sleep apnoea and incident malignancy in type 2 diabetes.

Authors:  Sarah Driendl; Michael Arzt; Claudia S Zimmermann; Bettina Jung; Tobias Pukrop; Carsten A Böger; Sebastian Haferkamp; Florian Zeman; Iris M Heid; Stefan Stadler
Journal:  ERJ Open Res       Date:  2021-05-04

6.  Identifying Obstructive Sleep Apnea Syndrome-Associated Genes and Pathways through Weighted Gene Coexpression Network Analysis.

Authors:  Yan Li; Li Li; Hua Zhao; Xiwen Gao; Shanqun Li
Journal:  Comput Math Methods Med       Date:  2022-01-29       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.